by Eric Christianson | Oct 24, 2021 | Clinical Pharmacy News and New Drug Updates
FDA-approved biosimilars have been compared to a biologic and shown to be highly similar in structure and function. They are determined to have no clinically meaningful differences in safety, purity, or potency. At the time this article was written, there are...
